Indeed, with governance of developmental features such as stem cell maintenance and involvement in EMT, FOXI3 may enable resistance to chemotherapy or tumor metastasis (Anders and Carey, 2008; Chaffer et al., 2016). The gene discussed is FOXI3; the disease is neoplasm.